Markets:

Overview

News

Currencies

International

Treasuries

DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)

7.050 -0.240 (-3.29%)

Streaming Delayed Price Updated: 10:16 AM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DiaMedica Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill ↗

July 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial - Read Why ↗

July 07, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 07, 2022

Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about!

Via InvestorPlace

Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session ↗

July 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special...

Via Benzinga

DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199

July 06, 2022

From DiaMedica Therapeutics

Via Business Wire

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

DiaMedica Therapeutics to Attend the 19th Annual Craig-Hallum Institutional Investor Conference Wednesday, June 1, 2022

May 25, 2022

From DiaMedica Therapeutics

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results

May 04, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Earnings Preview For DiaMedica Therapeutics ↗

May 03, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

DiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022

April 28, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results

March 14, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Earnings Scheduled For March 14, 2022 ↗

March 14, 2022

Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

DiaMedica Therapeutics Earnings Preview ↗

March 11, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement....

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

DiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial Officer

February 02, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Present Research at International Stroke Conference

January 25, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer

January 05, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event

December 13, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 17, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results

November 10, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021

November 09, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces Addition of Stroke Recurrence as a Second Independent Primary Endpoint in ReMEDy2 Phase 2/3 AIS Trial

November 08, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021

November 04, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces Late Breaking Data from REDUX Phase 2 Trial to be Presented at ASN Kidney Week 2021

October 18, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

DiaMedica Therapeutics Announces Fast Track Designation Granted to DM199 for the Treatment of Acute Ischemic Stroke

September 30, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

DiaMedica Therapeutics Announces Closing of $30 Million Private Placement

September 28, 2021

From DiaMedica Therapeutics Inc.

Via Business Wire

50 Biggest Movers From Yesterday ↗

September 28, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.